Not Rated
|
Fund Size
(0.54% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 21-Nov-25 | 10114.40 | 1.14% | - | 0.63% | 39/237 |
| 1 Month | 28-Oct-25 | 9960.90 | -0.39% | - | 0.00% | 144/240 |
| 3 Month | 28-Aug-25 | 10147.00 | 1.47% | - | 4.84% | 207/237 |
| 6 Month | 28-May-25 | 10586.70 | 5.87% | - | 5.86% | 102/226 |
| YTD | 01-Jan-25 | 9754.40 | -2.46% | - | 4.55% | 166/211 |
| 1 Year | 28-Nov-24 | 10408.80 | 4.09% | 4.09% | 4.70% | 102/199 |
| 2 Year | 28-Nov-23 | 14428.10 | 44.28% | 20.09% | 17.66% | 46/155 |
| 3 Year | 28-Nov-22 | 17642.40 | 76.42% | 20.81% | 18.43% | 40/128 |
| 5 Year | 27-Nov-20 | 21860.00 | 118.60% | 16.91% | 20.01% | 72/104 |
| Since Inception | 02-Jul-18 | 38725.00 | 287.25% | 20.04% | 12.46% | 35/219 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 28-Nov-24 | 12000 | 12475.23 | 3.96 % | 7.38 % |
| 2 Year | 28-Nov-23 | 24000 | 26827.48 | 11.78 % | 11.08 % |
| 3 Year | 28-Nov-22 | 36000 | 47588.06 | 32.19 % | 18.95 % |
| 5 Year | 27-Nov-20 | 60000 | 91694.72 | 52.82 % | 16.96 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 3388.9 | 12.01% | 0.44% | 12.5% (Apr 2025) | 10.74% (Jul 2025) | 20.04 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 2504.4 | 8.88% | 1.12% | 8.88% (Oct 2025) | 5.35% (Nov 2024) | 3.72 L | -5.00 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1808.1 | 6.41% | -0.56% | 7.24% (Jul 2025) | 5.22% (Apr 2025) | 9.56 L | -0.30 L |
| Apollo Hospitals Enterprises Ltd. | Hospital | 1751.6 | 6.21% | -0.02% | 6.37% (Jun 2025) | 4.82% (Dec 2024) | 2.28 L | -4.00 k |
| Cipla Ltd. | Pharmaceuticals | 1528.4 | 5.42% | -0.61% | 7.6% (Feb 2025) | 5.42% (Oct 2025) | 10.18 L | -0.90 L |
| Lupin Ltd. | Pharmaceuticals | 1431.7 | 5.07% | 0.03% | 6.37% (Apr 2025) | 4.94% (Jul 2025) | 7.29 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1220.6 | 4.33% | 0.14% | 4.33% (Oct 2025) | 2.12% (Jan 2025) | 11.93 L | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 1153.1 | 4.09% | -0.24% | 7.62% (Dec 2024) | 4.09% (Oct 2025) | 10.12 L | -0.90 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 1133.5 | 4.02% | -0.18% | 6.38% (Dec 2024) | 4.02% (Oct 2025) | 9.46 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 1064 | 3.77% | 0.03% | 4.32% (Nov 2024) | 3.57% (Feb 2025) | 14.76 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.78% |
| MF Units | MF Units | 0.01% |
| Net Receivables | Net Receivables | -0.10% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | 3.67 | 17.90 | 53.98 | 58.76 | 36.99 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | -0.22 | 4.72 | 16.52 | 29.87 | 15.41 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | -1.25 | 9.54 | 18.32 | 22.89 | 13.30 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 1.47 | 11.19 | 16.24 | 22.52 | 0.00 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -0.77 | 5.55 | 19.99 | 19.71 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 2.83 | 12.32 | 9.66 | 19.18 | 13.62 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.34 | 10.78 | 7.35 | 19.13 | 0.00 |
| Nippon India Japan Equity Fund - Growth | NA | 292.35 | -0.39 | 2.73 | 10.55 | 18.85 | 15.16 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.47 | 10.59 | 11.34 | 18.48 | 19.71 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 2.89 | 11.40 | 10.00 | 18.11 | 17.43 |
Out of 102 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 6 is/are ranked 4 * , 5 is/are ranked 3 * , 4 is/are ranked 2 * , and 85 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Large & Midcap Fund - Growth | 3 | 42980.74 | 0.73 | 6.66 | 8.67 | 8.05 | 17.01 |
| Mirae Asset Large Cap Fund - Regular - Growth | 3 | 41087.55 | 1.18 | 4.99 | 6.60 | 8.07 | 12.96 |
| Mirae Asset ELSS Tax Saver Fund - Regular Plan - Growth | 4 | 27069.09 | 0.42 | 5.96 | 8.02 | 8.48 | 16.96 |
| Mirae Asset Midcap Fund - Regular Plan - Growth | 3 | 18112.14 | 1.06 | 6.58 | 11.48 | 9.67 | 20.57 |
| Mirae Asset Liquid Fund - Growth | 4 | 14283.52 | 0.49 | 1.44 | 2.94 | 6.59 | 6.97 |
| Mirae Asset Aggressive Hybrid Fund - Growth | 3 | 9424.67 | 0.78 | 4.61 | 5.78 | 7.67 | 13.49 |
| Mirae Asset Focused Fund - Growth | 2 | 7979.98 | -1.23 | 1.22 | 3.87 | 2.11 | 10.91 |
| Mirae Asset Great Consumer Fund - Growth | NA | 4769.48 | -1.95 | 0.28 | 6.58 | 4.21 | 17.04 |
| Mirae Asset Nifty 50 ETF (MAN50ETF) | 4 | 4714.74 | 1.00 | 6.24 | 6.54 | 9.28 | 13.49 |
| Mirae Asset Nifty 50 ETF (MAN50ETF) | 4 | 4714.74 | 1.00 | 6.24 | 6.54 | 9.28 | 13.49 |